CLINICAL_TRIALS
research
· 2026-01-14
Clinical Trial Update: Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery [Phase 2]
Summary
A Phase 2 clinical trial is evaluating a chemo-immunotherapy regimen in patients with resectable Merkel cell carcinoma before surgical resection. The study stat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING